10-Mar-2008 - Alfa Laval has introduced new plate technology for the continuous production of pharmaceuticals, fine chemicals and speciality chemicals that has "the potential to start something of a revolution in the chemicals industry", the Swedish company claims.
Link to Article
in-pharmatechnologist.com
|
|
||||
|
This Month
Month Archive
RSS Newsfeeds
Main Page RSS
|
Monday, March 10
Continuous reactor promises production 'revolution'
by
Alex Hsieh on behalf of Professor Henry Wang
on Mon 10 Mar 2008 11:06 PM EDT
US pharma RFID market set for 60 per cent growth
by
Alex Hsieh on behalf of Professor Henry Wang
on Mon 10 Mar 2008 11:05 PM EDT
10-Mar-2008 - The promise of genuine returns on investment, facilitated by plummeting hardware costs, will fuel a dramatic growth surge in the US market for radio frequency identification (RFID) technology in pharmaceutical manufacturing and distribution over the next five years, a new report predicts.
Link to Article in-pharmatechnologist.com
Drug cuts risk of breast cancer returning
by
Lyle
on Mon 10 Mar 2008 11:04 PM EDT
Flu outbreak could put big cities on lockdown
by
Lyle
on Mon 10 Mar 2008 11:03 PM EDT
ACIP recommendations are a seasonal bounty for FluMist
by
Lyle
on Mon 10 Mar 2008 10:51 PM EDT
10-Mar-2008 - MedImmune is taking advantage of a new US recommendation on the immunisation of school children to almost triple production of its intranasal influenza vaccine, FluMist, for the coming 'flu season.
Link to Article In-Pharmatechnologist.com
Heparin contamination emerges after FDA China investigation
by
Lyle
on Mon 10 Mar 2008 10:50 PM EDT
07-Mar-2008 - A US Food and Drug Administration (FDA) investigation into the recent Baxter heparin scare has uncovered a contaminant in the product that was sourcing the active pharmaceutical ingredient (API) from a Chinese manufacturer.
Link to Article In-Pharmatechnologist.com
F.D.A. Expands Warnings on Anemia Drugs
by
Lyle
on Mon 10 Mar 2008 10:37 PM EDT
FDA adds black box warning to anemia drugs
by
Lyle
on Mon 10 Mar 2008 10:36 PM EDT
Vaccine settlement no landmark, officials say
by
Lyle
on Mon 10 Mar 2008 10:35 PM EDT
Eli Lilly drops inhaled insulin program
by
Lyle
on Mon 10 Mar 2008 10:32 PM EDT
Deal in an Autism Case Fuels Debate on Vaccine
by
Lyle
on Mon 10 Mar 2008 10:31 PM EDT
Despite studies’ failure to show any link between vaccines and autism, skeptics say a settlement in the case of 9-year-old Hannah Poling shows that they have been right along.
Link to Article NYTimes.com
GEN News Highlights - 3/7/08
by
Lyle
on Mon 10 Mar 2008 10:29 PM EDT
Link to All Articles
Mar 06 2008, 12:25 PM EST Amgen Pays $100M Upfront for Kyowa Hakko's Inflammation and Oncology mAb An additional $420 million is dependent on attaining development milestones of this early-stage candidate.Full Story Mar 06 2008, 12:21 PM EST Millipore Expands Portfolio of Animal-Free Cell Culture Supplements through Agreement with Solabia Firm gains exclusive rights to seven plant-derived hydrolysates.Full Story Mar 05 2008, 01:27 PM EST Molecular Alliance Identified that Sustains Embryonic Stem-Cell State A core Klf circuitry regulates self-renewal, according to a Nature Cell Biology paper.Full Story Mar 05 2008, 12:50 PM EST PanGenetics Closes Series C Round with $35M in Its Pocket Funding will help company begin clinical development of psoriatic arthritis and chronic pain compounds.Full Story Mar 04 2008, 11:34 AM EST Adnavance Opens Lab to Further Its Molecular Diagnostic Platform Facility will be used for R&D on the firm's M-DNA™ technology, which is touted to obviate target and signal amplification used in current tests.Full Story Mar 04 2008, 11:31 AM EST Biotage Signs Two-Year Extension of Molecular Imaging Agreement with McMaster University Collaborators will use the Biotage Initiator on more radionuclides and probes to create novel agents.Full Story Mar 03 2008, 12:26 PM EST Neurobiological Technologies Allies with Buck Institute for Alzheimer's Disease Drug Development Neurobiological will fund a three-year joint research project, with $1.2 million in the first year, and gains exclusive rights for $175,000.Full Story Mar 03 2008, 12:24 PM EST OneWorld Health, Amyris, and Sanofi-Aventis to Create a Complementary Source for Key Ingredient of Malaria Therapy The goal is to develop semisynthetic artemisinin and introduce it by 2010.Full Story Mar 03 2008, 12:39 PM EST Pfizer to Procure Serenex for Access to Hsp90 Pipeline Deal will add an early-stage anticancer agent, preclinical oncology and nononcology compounds, and discovery platform.Full Story Feb 29 2008, 11:25 AM EST Investigators Identify Human Gene that Bars HIV in Culture Study published in PLoS Pathogens showed that TRIMM22 prevents the assembly of the virus.Full Story GenEngNews.com |
Search
Links
|
||